Amphion Innovations (AMP)

 

Latest News

Holding(s) in Company

RNS Number: 6347R Motif Bio PLC 25 September 2017 25 September 2017 Motif Bio plc ("Motif" or the "Group") Holding(s) in the Company Motif Bio plc (AIM: MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that it was informed on 22 September 2017 by Amphion Innovations plc ("Amphion") that a tot...

Sale of Partner Company Shares

RNS Number: 6345R Amphion Innovations PLC 25 September 2017 Amphion Innovations plc ("Amphion" or "the Company") Sale of Partner Company Shares London and New York: Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces that 4,390,000 shares in Partner Company, Motif Bio have been sold...

Amphion reduces stake in Motif Bio

Amphion Innovations has soled 1,700,000 shares in partner company, Motif Bio, in partial repayment of the loan facility or...

Sale of partner company shares

RNS Number: 2325P Amphion Innovations PLC 30 August 2017 Amphion Innovations plc ("Amphion" or "the Company") 30 August 2017 Sale of Partner Company Shares London and New York, Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that 1,700,000 shares in Partner Company, Motif ...

All News

DateHeadlineSource
26-11-15Additional Draw on Loan FacilityRNS
05-11-15Amphion partner company m2m to mergeStockMarketWire
05-11-15Partner Company m2m Imaging Corp. to mergeRNS
30-10-15Death of a Director - ReplacementRNS
30-10-15Amphion chairman passes awayStockMarketWire
30-10-15Death of a DirectorRNS
17-09-15Amphion CEO to present at London forum StockMarketWire
17-09-15Amphion to present in LondonRNS
16-09-15Director Deals - Amphion Innovations PLC (AMP)StockMarketWire
16-09-15Director Deals - Amphion Innovations PLC (AMP)StockMarketWire
16-09-15Director Deals - Amphion Innovations PLC (AMP)StockMarketWire
16-09-15Directors' DealingsRNS
10-09-15Amphion's DataTern wins patent ruling StockMarketWire
10-09-15DataTern Receives Favourable RulingRNS
03-09-15FTSE rising on miners, airlines after US, Asia gainsStockMarketWire
03-09-15Amphion NAV jumps StockMarketWire
03-09-15Interim ResultsRNS
28-08-15Holding(s) in CompanyRNS
10-08-15Amphion resolutions passed at AGMStockMarketWire
07-08-15Result of AGMRNS
22-07-15FDA QIDP DesignationRNS
22-07-15Final condition of £22m placing satisfiedRNS
01-07-15Holding(s) in CompanyRNS
26-06-15Small-cap rockets: Double or quits?Interactive Investor
23-06-15Amphion partner company raises £22m StockMarketWire
23-06-15Partner Company raises £22 millionRNS
23-06-15Amphion pre-tax losses rise StockMarketWire
23-06-15Preliminary ResultsRNS
18-06-15Motif Bio's multi-billion dollar best-seller?Interactive Investor
05-06-15FTSE dips on retailers, miners as Tsipras probedStockMarketWire
05-06-15FTSE entrenches losses as VOD, retailers sourStockMarketWire
05-06-15Amphion raises £1.54m StockMarketWire
05-06-15Placing to raise £1.54 millionRNS
19-05-15Amphion appoints joint corporate broker StockMarketWire
19-05-15Appointment of brokerRNS
15-04-15Amphion partner get FDA go-ahead for iclaprim development StockMarketWire
15-04-15FDA ResultsRNS
07-04-15Amphion warrants exercised StockMarketWire
07-04-15Shares Issued for Exercised WarrantsRNS
02-04-15Amphion partner Motif floats on AIM StockMarketWire

RSS feeds

  • Editorial news feed for LSE:AMP Editorial
  • Regulatory news feed for LSE:AMP Regulatory